Company profile: Hospitex
1.1 - Company Overview
Company description
- Provider of cytology laboratory instruments and services, including CYTOfast Plus liquid-based cytology for thin-layer slides, CYTOfast Biobank for sample collection/preservation up to 8 weeks, BLOCKfast rapid cytoinclusion kit, CYTOfast Urine24 home urinary tract cancer screening, CYTOfast Vet24 veterinary thin-layer cytology with rapid reporting, and PapTest24 gynecological liquid-based cytology.
Products and services
- CYTOfast Plus: A liquid-based cytology system that produces thin-layer slides, optimizing cell representation and diagnostic accuracy, and promises the highest hourly productivity in the cytology industry
- PapTest24: A liquid-based gynecological cytology service delivering thin-layer slides for improved diagnostic accuracy in gynecological diagnostics
- CYTOfast Biobank: A vial-based system for collecting and preserving biological samples for cytological and molecular analysis, ensuring sample integrity for up to 8 weeks
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Hospitex
Lab21
HQ: United Kingdom
Website
- Description: Provider of personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow, reflecting the belief that prevention is better than cure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lab21 company profile →
Biomerica
HQ: United States
Website
- Description: Provider of advanced diagnostic products that it develops, manufactures, and markets, including EZ Detect, a home test for hidden blood in stool—an early warning sign of colorectal cancer—requiring no stool handling or dietary restrictions; InFoods IBS, a diagnostic identifying foods whose elimination may alleviate IBS symptoms; and Aware, an FDA-cleared breast self-exam device enhancing sensitivity for early detection of abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biomerica company profile →
Euroclinic
HQ: Italy
Website
- Description: Provider of high-tech medical equipment, specializing in the production and distribution of professional and diagnostic chairs and units.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Euroclinic company profile →
Nano Diagnostics
HQ: United States
Website
- Description: Provider of hand-held point-of-care diagnostics, including the NanoDx System with nanowire biosensor technology for results in minutes; a TBI test offering quantitative assessment via key biomarkers for screening and monitoring mild brain injury; a COVID-19 antigen test from nasal, throat, or saliva samples; and data management tools with EHR integration and a web portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nano Diagnostics company profile →
Paraytec
HQ: United Kingdom
Website
- Description: Provider of scientific instruments used for chemical and biological analysis, including miniaturized ultraviolet-visible absorbance detectors, developing and marketing these instruments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Paraytec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Hospitex
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Hospitex
2.2 - Growth funds investing in similar companies to Hospitex
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Hospitex
4.2 - Public trading comparable groups for Hospitex
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →